Explore Our Comprehensive Pharmaceuticals Industry Research Reports
U
2022
Generic drugs are pharmaceutical drugs with similar chemical makeup of a branded drug. Generic drugs are cheaper in Japan and equivalent to branded drugs in dosage, strength, route ...
Report Code : A03804 | Category : Life Sciences
P
2020
The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027.
Report Code : A07588 | Pages : 235 | Category : Life Sciences
P
2022
The U.S. pain management drugs market size was valued at $25,174.29 Million in 2021, and is projected to reach $34,824.24 Million by 2031, registering a CAGR of 3.3% ...
Report Code : A09451 | Pages : 183 | Category : Life Sciences
P
2021
The Gulf Pain Management Drugs Market size was valued at $851.08 million in 2019, and is projected to reach $1,047.91 million by 2027, registering a CAGR of 3.2%.
Report Code : A10353 | Pages : 159 | Category : Life Sciences
U
2024
Intranasal drugs are an important part of migraine treatment. Migraine headache attacks are prevented by using these medicines. It assists in reducing headache pain and other symptoms like ...
Report Code : A12660 | Category : Life Sciences
P
2021
The India, Bangladesh, Sri Lanka, Nepal pet parasiticides market size was valued at $14,772.23 thousand in 2020, and is projected to reach $23,944.89 thousand by 2030, registering a ...
Report Code : A14890 | Pages : 146 | Category : Life Sciences
P
2023
The North America Anti-Obesity Drugs Market is segmented based on drug type, mechanism of action, route of administration, distribution channel. Depending on Distribution Channel segment, the Hospital Pharmacies sub-segment is expected to register significant CAGR during the forecast period.
Report Code : A103545 | Pages : 117 | Category : Life Sciences
P
2023
Distribution Channel segment is projected to create abundant revenue opportunity till 2032. Leading players in U.S. Anti-Obesity Drugs Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.
Report Code : A103546 | Pages : 72 | Category : Life Sciences
P
2023
In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. Distribution Channel was the leading segment.
Report Code : A103547 | Pages : 87 | Category : Life Sciences
P
2023
In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. Distribution Channel was the leading segment.
Report Code : A103548 | Pages : 84 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.